LLY
936.53
+0.86%↑
JNJ
186.34
-0.01%↓
UNH
321.47
-2%↓
NVS
126.4
+0.75%↑
ABT
124.91
+0.22%↑
LLY
936.53
+0.86%↑
JNJ
186.34
-0.01%↓
UNH
321.47
-2%↓
NVS
126.4
+0.75%↑
ABT
124.91
+0.22%↑
LLY
936.53
+0.86%↑
JNJ
186.34
-0.01%↓
UNH
321.47
-2%↓
NVS
126.4
+0.75%↑
ABT
124.91
+0.22%↑
LLY
936.53
+0.86%↑
JNJ
186.34
-0.01%↓
UNH
321.47
-2%↓
NVS
126.4
+0.75%↑
ABT
124.91
+0.22%↑
LLY
936.53
+0.86%↑
JNJ
186.34
-0.01%↓
UNH
321.47
-2%↓
NVS
126.4
+0.75%↑
ABT
124.91
+0.22%↑
24h
Current
Min
6.98
Max
7.32
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +235.15% upside |
Next Earnings | 10 lis 2025 |
|---|
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
27 lis 2024, 13:34 UTC
CervoMed Shares Rise 15% on FDA's Orphan Drug Designation for Neflamapimod
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 24.6 USD 235.15%
High 31 USD
Low 20 USD
Based on 5 Wall Street analysts offering 12 month price targets forCervoMed Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
5 ratings
5
Buy
0
Hold
0
Sell
Based on 5 analysts giving stock ratings to CervoMed Inc - Dist in the past 3 months.
$